278 related articles for article (PubMed ID: 16615007)
41. Phenotypic expression of HFE mutations: a French study of 1110 unrelated iron-overloaded patients and relatives.
Moirand R; Jouanolle AM; Brissot P; Le Gall JY; David V; Deugnier Y
Gastroenterology; 1999 Feb; 116(2):372-7. PubMed ID: 9922318
[TBL] [Abstract][Full Text] [Related]
42. Major histocompatibility complex class I associations in iron overload: evidence for a new link between the HFE H63D mutation, HLA-A29, and non-classical forms of hemochromatosis.
Porto G; Alves H; Rodrigues P; Cabeda JM; Portal C; Ruivo A; Justiça B; Wolff R; De Sousa M
Immunogenetics; 1998 Apr; 47(5):404-10. PubMed ID: 9510559
[TBL] [Abstract][Full Text] [Related]
43. Asymptomatic hemochromatosis subjects: genotypic and phenotypic profiles.
Sham RL; Raubertas RF; Braggins C; Cappuccio J; Gallagher M; Phatak PD
Blood; 2000 Dec; 96(12):3707-11. PubMed ID: 11090050
[TBL] [Abstract][Full Text] [Related]
44. HFE C282Y/H63D compound heterozygotes are at low risk of hemochromatosis-related morbidity.
Gurrin LC; Bertalli NA; Dalton GW; Osborne NJ; Constantine CC; McLaren CE; English DR; Gertig DM; Delatycki MB; Nicoll AJ; Southey MC; Hopper JL; Giles GG; Anderson GJ; Olynyk JK; Powell LW; Allen KJ;
Hepatology; 2009 Jul; 50(1):94-101. PubMed ID: 19554541
[TBL] [Abstract][Full Text] [Related]
45. Iron overload is rare in patients homozygous for the H63D mutation.
Kelley M; Joshi N; Xie Y; Borgaonkar M
Can J Gastroenterol Hepatol; 2014 Apr; 28(4):198-202. PubMed ID: 24729993
[TBL] [Abstract][Full Text] [Related]
46. HFE mutations in Caucasian participants of the Hemochromatosis and Iron Overload Screening study with serum ferritin level <1000 µg/L.
Adams PC; McLaren CE; Speechley M; McLaren GD; Barton JC; Eckfeldt JH
Can J Gastroenterol; 2013 Jul; 27(7):390-2. PubMed ID: 23862168
[TBL] [Abstract][Full Text] [Related]
47. An open population screening study for HFE gene major mutations proves the low prevalence of C282Y mutation in Central Italy.
Floreani A; Rosa Rizzotto E; Basso D; Navaglia F; Zaninotto M; Petridis I; DI Andrea O; Testa R; Marra M; Baldo V; Chiaramonte M
Aliment Pharmacol Ther; 2007 Aug; 26(4):577-86. PubMed ID: 17661761
[TBL] [Abstract][Full Text] [Related]
48. Compound heterozygous hemochromatosis genotype predicts increased iron and erythrocyte indices in women.
Rossi E; Olynyk JK; Cullen DJ; Papadopoulos G; Bulsara M; Summerville L; Powell LW
Clin Chem; 2000 Feb; 46(2):162-6. PubMed ID: 10657371
[TBL] [Abstract][Full Text] [Related]
49. Correlation between iron status and genetic hemochromatosis (codon C282Y) in a large German population.
Wrede CE; Hutzler S; Bollheimer LC; Buettner R; Hellerbrand C; Schöelmerich J; Palitzsch KD
Isr Med Assoc J; 2004 Jan; 6(1):30-3. PubMed ID: 14740507
[TBL] [Abstract][Full Text] [Related]
50. Hereditary hemochromatosis in north-eastern Romania.
Voicu PM; Cojocariu C; Petrescu-Dănilă E; Stanciu C; Covic M; Rusu M; Trifan A
Rev Med Chir Soc Med Nat Iasi; 2010; 114(4):982-7. PubMed ID: 21495455
[TBL] [Abstract][Full Text] [Related]
51. Analysis of HFE and TFR2 mutations in selected blood donors with biochemical parameters of iron overload.
De Gobbi M; Daraio F; Oberkanins C; Moritz A; Kury F; Fiorelli G; Camaschella C
Haematologica; 2003 Apr; 88(4):396-401. PubMed ID: 12681966
[TBL] [Abstract][Full Text] [Related]
52. Does bilirubin protect against hemochromatosis gene (HFE) related mortality?
Alizadeh BZ; Njajou OT; Houwing-Duistermaat JJ; de Jong G; Vergeer JM; Hofman A; Pols HA; van Duijn CM
Am J Med Genet A; 2004 Aug; 129A(1):39-43. PubMed ID: 15266614
[TBL] [Abstract][Full Text] [Related]
53. HFE gene mutations an Apulian population: allele frequencies.
Pietrapertosa A; Vitucci A; Campanale D; Palma A; Renni R; Delios G; Tannoia N
Eur J Epidemiol; 2003; 18(7):685-9. PubMed ID: 12952143
[TBL] [Abstract][Full Text] [Related]
54. Contribution of different HFE genotypes to iron overload disease: a pooled analysis.
Burke W; Imperatore G; McDonnell SM; Baron RC; Khoury MJ
Genet Med; 2000; 2(5):271-7. PubMed ID: 11399207
[TBL] [Abstract][Full Text] [Related]
55. Iron absorption by heterozygous carriers of the HFE C282Y mutation associated with hemochromatosis.
Hunt JR; Zeng H
Am J Clin Nutr; 2004 Oct; 80(4):924-31. PubMed ID: 15447900
[TBL] [Abstract][Full Text] [Related]
56. The clinical relevance of compound heterozygosity for the C282Y and H63D substitutions in hemochromatosis.
Walsh A; Dixon JL; Ramm GA; Hewett DG; Lincoln DJ; Anderson GJ; Subramaniam VN; Dodemaide J; Cavanaugh JA; Bassett ML; Powell LW
Clin Gastroenterol Hepatol; 2006 Nov; 4(11):1403-10. PubMed ID: 16979952
[TBL] [Abstract][Full Text] [Related]
57. Prevalence of C282Y, H63D, and S65C mutations in hereditary HFE-hemochromatosis gene in Lithuanian population.
Kucinskas L; Juzenas S; Sventoraityte J; Cedaviciute R; Vitkauskiene A; Kalibatas V; Kondrackiene J; Kupcinskas L
Ann Hematol; 2012 Apr; 91(4):491-5. PubMed ID: 21947086
[TBL] [Abstract][Full Text] [Related]
58. Clinical manifestations of hemochromatosis in HFE C282Y homozygotes identified by screening.
McLaren GD; McLaren CE; Adams PC; Barton JC; Reboussin DM; Gordeuk VR; Acton RT; Harris EL; Speechley MR; Sholinsky P; Dawkins FW; Snively BM; Vogt TM; Eckfeldt JH;
Can J Gastroenterol; 2008 Nov; 22(11):923-30. PubMed ID: 19018338
[TBL] [Abstract][Full Text] [Related]
59. Screening selected blood donors with biochemical iron overload for hemochromatosis: a regional experience.
De Gobbi M; D'Antico S; Castagno F; Testa D; Merlini R; Bondi A; Camaschella C
Haematologica; 2004 Oct; 89(10):1161-7. PubMed ID: 15477198
[TBL] [Abstract][Full Text] [Related]
60. Hemochromatosis genotypes and risk of iron overload--a meta-analysis.
Neghina AM; Anghel A
Ann Epidemiol; 2011 Jan; 21(1):1-14. PubMed ID: 20800508
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
